
1. malar j. 2020 may 24;19(1):190. doi: 10.1186/s12936-020-03263-z.

prevalence pfdhfr pfdhps mutations plasmodium falciparum associated
with drug resistance among pregnant women receiving iptp-sp msambweni county
referral hospital, kwale county, kenya.

gikunju sw(1)(2), agola el(3)(4), ondondo ro(5), kinyua j(6), kimani f(3),
labeaud ad(7), malhotra i(8), king c(8), thiong'o k(3), mutuku f(9).

author information: 
(1)jomo kenyatta university agriculture technology (jkuat), nairobi,
kenya. stl.gikunju@gmail.com.
(2)kenya medical research institute (kemri), centre biotechnology research
and development (cbrd), nairobi, kenya. stl.gikunju@gmail.com.
(3)kenya medical research institute (kemri), centre biotechnology research
and development (cbrd), nairobi, kenya.
(4)technical university kenya, nairobi, kenya.
(5)masinde muliro university science technology, kakamega, kenya.
(6)jomo kenyatta university agriculture technology (jkuat), nairobi,
kenya.
(7)department pediatrics, division infectious disease, stanford university 
school medicine, stanford, ca, usa.
(8)center global health diseases, case western reserve university,
cleveland, oh, usa.
(9)department environment health sciences, technical university of
mombasa, mombasa, kenya.

background: prevention treatment malaria pregnancy crucial in
dealing maternal mortality adverse fetal outcomes. world health
organization recommendation treat pregnant women with
sulfadoxine-pyrimethamine (sp) antenatal care structures implemented 
in kenya year 1998, concerns effectiveness preventing
malaria pregnancy arisen due spread sp resistant parasites. this
study aimed determine prevalence sp resistance markers plasmodium
falciparum parasites isolated pregnant women seeking antenatal care at
msambweni county referral hospital, located coastal kenya, year
2013 2015.
methods: hospital-based study included 106 malaria positive whole blood
samples analysis sp resistance markers within pfdhfr gene (codons 51, 
59 108) pfdhps gene (codons 437 540). venous blood collected from
all pregnant women tested malaria via light microscopy, malaria 
positive samples separated plasma red cells stored - 86°
freezer studies. archived red blood cells processed for
molecular characterization sp resistance markers within pfdhfr pfdhps 
genes using real time pcr platform sanger sequencing.
results: samples least one mutation genes associated drug 
resistance; polymorphism prevalence pfdhfr51i, 59r 108n 88.7%,
78.3% 93.4%, respectively, pfdhps polymorphism accounted 94.3% 
91.5% 437g 540e, respectively. quintuple mutations (at five
codons) conferring total sp resistance highest prevalence 85.8%.
quadruple mutations observed frequency 10.4%, 24.5% mixed 
outcome wildtype mutant genotypes genes interest.
conclusion: data suggest high prevalence p. falciparum genetic
variations conferring resistance sp among pregnant women, may explain
reduced efficacy iptp treatment kenya. need extensive sp
resistance profiling kenya inform iptp drug choices successful malaria 
prevention pregnancy.

doi: 10.1186/s12936-020-03263-z 
pmcid: pmc7247205
pmid: 32448228 

